Home Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA
 

Keywords :   


Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

2016-01-17 19:50:21| Biotech - Topix.net

Novartis announced today that the US Food and Drug Administration has approved Cosentyx for two new indications - the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis . AS and PsA are both life-long, painful and debilitating inflammatory diseases that affect the joints and/or spine.

Tags: with treatment adult approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
01.06Mining for Pearlizing Agent 
01.06The Power of Zinc Pyrithione
01.06Downward pH Drift
01.06Adding Fragrances to Hot Pours
01.06The Perils of Progress in the Search for New UV Filters
01.06This Interview Formality Jumpstarts Or Kills Your Chances Altogether
More »